Ned Davis Research Initiates Coverage on Insulet Corp. (PODD)
Equities researchers at Ned Davis Research assumed coverage on shares of Insulet Corp. (NASDAQ:PODD) in a research report issued on Monday, Analyst Ratings.Net reports. The firm set a “neutral” rating on the stock.
A number of other firms have also recently commented on PODD. Analysts at JMP Securities downgraded shares of Insulet Corp. from an “outperform” rating to a “market perform” rating in a research note to investors on Friday, September 20th. They now have a $33.00 price target on the stock. Separately, analysts at Jefferies Group raised their price target on shares of Insulet Corp. from $29.00 to $38.00 in a research note to investors on Friday, August 9th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and five have issued a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $30.77.
Insulet Corp. (NASDAQ:PODD) traded down 1.12% on Monday, hitting $37.22. The stock had a trading volume of 320,796 shares. Insulet Corp. has a 1-year low of $18.50 and a 1-year high of $38.27. The stock’s 50-day moving average is $35. and its 200-day moving average is $30.77. The company’s market cap is $2.025 billion.
Insulet Corp. (NASDAQ:PODD) last issued its quarterly earnings data on Wednesday, August 7th. The company reported ($0.20) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.19) by $0.01. The company had revenue of $60.09 million for the quarter, compared to the consensus estimate of $60.47 million. During the same quarter last year, the company posted ($0.30) earnings per share. Insulet Corp.’s revenue was up 17.7% compared to the same quarter last year.
Insulet Corporation is primarily engaged in the development, manufacturing and sale of its OmniPod Insulin Management System (NASDAQ:PODD).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.